OTCMKTS:FSNUY Fresenius SE & Co. Q1 2025 Earnings Report $13.09 +0.09 (+0.69%) As of 09/11/2026 03:59 PM Eastern ProfileEarnings HistoryForecast Fresenius SE & Co. EPS ResultsActual EPS$0.23Consensus EPS $0.22Beat/MissBeat by +$0.01One Year Ago EPSN/AFresenius SE & Co. Revenue ResultsActual Revenue$5.92 billionExpected Revenue$5.41 billionBeat/MissBeat by +$513.12 millionYoY Revenue GrowthN/AFresenius SE & Co. Announcement DetailsQuarterQ1 2025Date5/7/2025TimeBefore Market OpensConference Call DateN/AConference Call TimeN/AUpcoming EarningsFresenius SE & Co.'s next earnings date is estimated for Wednesday, November 4, 2026, based on past reporting schedules. Conference Call ResourcesEarnings HistoryCompany Profile Fresenius SE & Co. Earnings HeadlinesFresenius Kabi and AABB Announce 21st Annual Blood Collectors Week, September 6–12, 2026, Honoring Lifesaving Blood Collection ProfessionalsSeptember 6, 2026 | markets.ft.comFresenius SE Ups Guidance After Robust Earnings CallAugust 25, 2026 | tipranks.comTicker Revealed: Pre-IPO Access to "Next Elon Musk" CompanyWe’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billion in government contracts. Peter Thiel just bet $1 Billion on it.September 13 at 1:00 AM | Banyan Hill Publishing (Ad)Fresenius SE & Co. KGaA (FSNUY) Q2 2026 Earnings Call TranscriptAugust 5, 2026 | seekingalpha.comFresenius Lifts Earnings Outlook on Hospitals, Drug StrengthAugust 5, 2026 | bloomberg.comFresenius (XTRA:FRE) Stock May Still Be Cheap On Its 66% RunJuly 30, 2026 | finance.yahoo.comSee More Fresenius SE & Co. Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Fresenius SE & Co.? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Fresenius SE & Co. and other key companies, straight to your email. Email Address About Fresenius SE & Co.Fresenius SE & Co. (OTCMKTS:FSNUY) KGaA is a Germany-based global health care company headquartered in Bad Homburg. The company develops and provides products and services for hospitals, outpatient care, and patients with chronic or complex medical conditions. Its principal operating businesses are Fresenius Kabi and Fresenius Helios. Fresenius Kabi supplies medicines, clinical nutrition products, infusion and transfusion technologies, and related devices and services. Fresenius Helios operates hospitals and outpatient facilities, primarily in Germany and Spain, providing a broad range of medical and surgical care. Fresenius traces its origins to a pharmacy established by the Fresenius family in Frankfurt in the 15th century and has evolved into an international health care group serving markets across Europe, North America, Latin America, Asia, and other regions. Michael Sen has served as chief executive officer since 2022. The company previously operated through additional health care services businesses, including Vamed, before simplifying its portfolio around Kabi and Helios.View Fresenius SE & Co. ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles MarketBeat Week in Review – 09/07 - 09/11Kroger’s Textbook Entry for Buy-and-Hold InvestorsOracle’s AI Spending Is Still Huge, But the Payoff Is Starting to Show in EarningsAmgen Drops 10% on a Trial It Didn't Even RunOil Above $100 Is Creating a New Opportunity Beyond the Major ProducersAST SpaceMobile Looks to Extend Its 30-Day FCC Satellite Testing WindowAmerican Eagle Goes on Sale: Is It Time to Buy? Upcoming Earnings Cintas (9/23/2026)Costco Wholesale (9/24/2026)Micron Technology (9/30/2026)NIKE (10/1/2026)Accenture (10/1/2026)PepsiCo (10/8/2026)Delta Air Lines (10/8/2026)America Movil (10/13/2026)BlackRock (10/13/2026)Citigroup (10/13/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
